Veeva Systems (NYSE:VEEV – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 7.320-7.320 for the period, compared to the consensus EPS estimate of 6.970. The company issued revenue guidance of $3.0 billion-$3.1 billion, compared to the consensus revenue estimate of $3.1 billion. Veeva Systems also updated its Q1 2026 guidance to 1.740-1.750 EPS.
Veeva Systems Stock Up 0.9 %
VEEV traded up $1.87 during trading hours on Wednesday, reaching $220.32. 1,491,476 shares of the company’s stock traded hands, compared to its average volume of 1,057,440. The firm has a 50-day moving average price of $223.76 and a 200 day moving average price of $219.53. The firm has a market capitalization of $35.77 billion, a PE ratio of 54.40, a PEG ratio of 1.89 and a beta of 0.85. Veeva Systems has a 52-week low of $170.25 and a 52-week high of $258.93.
Veeva Systems (NYSE:VEEV – Get Free Report) last issued its earnings results on Wednesday, March 5th. The technology company reported $1.19 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.58 by ($0.39). Veeva Systems had a net margin of 25.07% and a return on equity of 13.56%. Equities analysts predict that Veeva Systems will post 4.35 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Check Out Our Latest Stock Analysis on VEEV
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- Growth Stocks: What They Are, What They Are Not
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.